BRCA2 protein deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure
about
The tell-tale heart: molecular and cellular responses to childhood anthracycline exposureSmall-Molecule Procaspase-3 Activation Sensitizes Cancer to Treatment with Diverse ChemotherapeuticsIdentification of differentially methylated BRCA1 and CRISP2 DNA regions as blood surrogate markers for cardiovascular diseaseBRCA2 variants and cardiovascular disease in a multi-ethnic study.Sleep is not just for the brain: transcriptional responses to sleep in peripheral tissues.Use of (99m)Tc-doxorubicin scintigraphy in females with breast cancer: a pilot study.Ataxia telangiectasia mutated in cardiac fibroblasts regulates doxorubicin-induced cardiotoxicity.Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues.An Exploratory Study to Determine Whether BRCA1 and BRCA2 Mutation Carriers Have Higher Risk of Cardiac Toxicity.Drug-induced oxidative stress and toxicity.Inactivation of BRCA2 in human cancer cells identifies a subset of tumors with enhanced sensitivity towards death receptor-mediated apoptosis.Silencing of BRCA2 decreases anoikis and its heterologous expression sensitizes yeast cells to acetic acid-induced programmed cell death.Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines.Commercially available lifestyle modification program: randomized controlled trial addressing heart and bone health in BRCA1/2+ breast cancer survivors after risk-reducing salpingo-oophorectomy.Investigation of TGFβ1-Induced Long Noncoding RNAs in Endothelial CellsPremature ovarian aging in BRCA carriers: a prototype of systemic precocious aging?
P2860
Q26823592-CF341867-C1BA-4262-BC20-B4C87A72F66AQ29027136-B91A52B9-120F-431A-958E-D1185BA60B10Q33895047-47830EFF-1B0C-408E-B3C9-750DAB0D9A32Q34342912-47E20541-8718-46E6-B1E6-9EC99B59DF01Q34747874-4D7C6733-6926-48A0-8BDB-E307725EAF98Q36295637-3F936C54-FFF6-4FBE-8176-1A8E88437E9FQ36702443-1ECD1BAB-26E3-4FCE-B9E8-018C21ABC588Q36887091-1AE4AA95-6E99-4D3A-A9EF-64FE6D0E17AAQ37676233-757DDBE6-3397-4770-97B1-F027435AB30BQ38037517-492E6C1A-270C-4670-AACC-16772D9EBAE5Q38796779-89A72AE1-0AD9-4220-A25C-A73E97B4F392Q38987920-E67080DA-FD2E-4872-8F44-0DB1B8929E85Q40124999-09424B55-B2F6-4909-91F3-7913AC59F589Q40462939-A2DC896F-D723-4EF3-8CFF-B9F622B9D296Q40531381-4321D682-3941-42DE-9EEB-E81444067B84Q54941261-AFC3277E-1B7C-49BC-B24D-710834D585A2
P2860
BRCA2 protein deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
BRCA2 protein deficiency exagg ...... apoptosis and cardiac failure
@ast
BRCA2 protein deficiency exagg ...... apoptosis and cardiac failure
@en
type
label
BRCA2 protein deficiency exagg ...... apoptosis and cardiac failure
@ast
BRCA2 protein deficiency exagg ...... apoptosis and cardiac failure
@en
prefLabel
BRCA2 protein deficiency exagg ...... apoptosis and cardiac failure
@ast
BRCA2 protein deficiency exagg ...... apoptosis and cardiac failure
@en
P2093
P2860
P50
P356
P1476
BRCA2 protein deficiency exagg ...... apoptosis and cardiac failure
@en
P2093
Adrian Quan
Ankit Garg
Fina Lovren
Howard Leong-Poi
Jean-François Desjardins
Krishna K Singh
Mohammed Al-Omran
Paul E Szmitko
Praphulla C Shukla
Subodh Verma
P2860
P304
P356
10.1074/JBC.M111.292664
P407
P577
2011-12-08T00:00:00Z